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SUMMARY 
The present studies were performed to evaluate the role of steroid precursors and plasma lipoproteins 
in gonadal tissue steroidogenesis. Leydig cell suspension isolated from rat testes responded to hCG. 
Bl,cAMP, 8 Br-CAMP and cholera toxin with an increase in testosterone response. Administration of 
4_aminopyrazolo[3,4_d]pyrimidine (CAPP) reduced the plasma cholesterol and testosterone levels in a 
time and dose dependent manner. This treatment also reduced the steroidogenic capacity of isolated 
Leydig cells both under basal conditions and in response to trophic hormone. Different doses of 4-APP 
up lo 25 mg/kg BW and up lo 4 days of treatment. however, did not modulate cholesterol and choles- 
terol ester contents of isolated Leydig cells. CAPP treatment also had no effect on testis weight, 
phospholipid content, protein synthesis and energy metabolism in isolated Leydig cells. Similarly, ad- 
ministration of CAPP (12.5 mg/kg) to PMSG-hCG primed cats beginning on day 3, post hCG, drasti- 
cally reduced the circulating cholesterol and progesterone levels. Injection of the drug also produced an 
inhibition in in vitro luteal cell steroidogenesis and a reduction in cellular cholesterol esters and free 
cholesterol contents. Addition of LDL or HDL to incubation medium reversed the inhibitory effect of 
CAPP on luteal cell steroidogenesis while this inhibition persisted in Leydig cells. Injection of rats with 
Triton-WR-1339 (mg/kg BW) resulted in a lo-fold increase in plasma cholesterol and a contrasting 
decrease in testosterone levels. This treatment, however, produced no effect on in vitro Leydig cell 
steroidogenesis or cellular content of cholesterol esters and free cholesterol. It appears that the Lcydig 
and luteal cells process and utilize lipoproteindelivered cholesterol for steroidogenesis through different 
mechanism(s). These studies thus demonstrate differential actions and an acute regulatory role of lipo- 
proteins in gonadotropin modulated steroidogenesis in two different gonadal tissue. 
INTRODUCTION 
The pituitary gonadotropins are the major regulators 
of steroidogenesis in gonadal tissues [l-5]. In recent 
years considerable progress has been made in deli- 
neating the mode of action of gonadotropins 
(LH/hCG) in target tissues [l-S]. Initial events in 
LH/hCG action, including hormone receptor interac- 
tion, adenylate cyclase activation and protein kinase 
stimulation have been extensively studied. However, 
the role that the steroid precursor, cholesterol, plays 
in the regulation of steroidogenesis has remained rela- 
tively unexplored. The fact that in gonadal tissues, 
cholesterol is not only utilized for membrane bioge- 
nesis but also serves as steroid precursor, suggests 
that its synthesis and availability could be an impor- 
tant factor in the regulation of steroidogenesis. 
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Recently, many investigators have demonstrated 
in the adrenal gland a close correlation between ex- 
ogenous vs endogenous cholesterol levels and the 
extent of tissue steroidogenesis [6-143. In contrast, to 
date, very limited information is available regarding 
the role of exogenous vs endogenous cholesterol in 
the regulation of gonadal tissue steroidogenesis 
[6,8,15-17-J. Further, although the steroidogenic 
tissues, adrenal, testis, ovary, and placenta all secrete 
steroid, the regulatory role exerted by cholesterol 
could be entirely different in each of these systems. 
In the present studies, attempts were made to ana- 
lyze systematically the effect of varying the plasma 
cholesterol levels on testicular cholesterol ester and 
free cholesterol content and the extent of gonadotro- 
pin induced steroidogenesis in isolated Leydig cells. 
This was accomplished by treating rats with Camino- 
pyrazolo[3,4-dlpyrimidine (CAPP) to lower the 
plasma lipoprotein and cholesterol levels [ 18,193 and 
by injection of Triton WR-1339 to raise the circulat- 
ing levels of cholesterol [20-223. Further, attempts 
were also made to compare the cholesterol require- 
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ments and lipoprotein utilization by ovarian (luteal) 
and testicular (Leydig) cells in gonadotropin induced 
steroidogenesis. These studies demonstrate that the 
two gonadal tissues exhibit considerable variation in 
their cholesterol requirements for gonadotropin 
induced steroidogenesis. 
MATERIALS AND METHODS 
Materials 
Human chorionic gonadotropin (hCG, CR-l 19, 
11,500 IU/mg) was generously supplied by Dr R. Can- 
field, Columbia University, New York, through Popu- 
lation Research Branch, National Institutes of Health, 
Bethesda, MD. 4-Amino-pyrazolo[3,4]pyrimidine 
(4-APP) and 1 methyl-3-isobutylxanthine (MIX) were 
obtained from Aldrich Chemical Co., Milwaukee, WI. 
Collagenase (CLS) Type I and deoxyribonuclease I 
were purchased from Worthington Biochemical 
Corp., Freehold, NJ. Cholera enterotoxin and preg- 
nant mare’s serum gonadotropin (PMSG) were sup 
plied by Schwarz/Mann and Organon OSS, Holland, 
respectively. 8 bromo-cyclic 3.5 adenosine monophos- 
phate (8 Br-CAMP), Triton WR-1339 (Toxapol) and 
partially purified human chorionic gonadotropin 
(hCG) were the products of Sigma Chemical Co., St. 
Louis, MO. Eagle’s Minimum Essential Medium with 
Earle’s salt, Medium 199 and Medium 109 were pur- 
chased from Grand Island Biological Co., Grand 
Island, NY. ‘2sI-choriogonadotropin was prepared 
according to Catt et a/.[23]. 
Isolation of Leydig cellsjiom rat testis 
Leydig cells from rat testis were prepared by a com- 
bination of procedures of Dufau et aI.[24] and Moyle 
and RamachandranCZS]. Testes from 50-60-day old 
Sprague-Dawley rats were excised free of fat and 
decapsulated. Groups of four decapsulated testes were 
added to 50ml conical polypropylene centrifuge tube 
containing 10ml Medium 199. 1 mglml bovine serum 
albumin (BSA) and 0.25 mg/ml collagenase (Type I). 
The tubes were gassed with 02/C02 (95/5x v/v), 
tightly capped, placed sideways in Dubonoff meta- 
bolic shaker and shaken at 100 cycles/min for 20 min 
at 37°C. At the end of incubation the tubes were filled 
to 4Oml mark with Medium 199-0.1% BSA, and 
gently inverted several times to facilitate the separ- 
ation of interstitial cells from the tubular mass. The 
tubules were allowed to settle for 10 min, and the tur- 
bid supernatant containing Leydig cells was carefully 
removed with a plastic disposable syringe attached to 
Tygon tubing. The sedimented tubular mass was 
washed once with 50 ml of the same medium and after 
allowing the tubes to remain for 10 min, the superna- 
tant was carefully removed. Both supernatants were 
combined and Leydig cells were sedimented at 1000 g 
for 15 min. The sedimented cells were washed two 
times in Medium 199-0.1% BSA and finally resus- 
pended in a desired volume of the same medium. 
Incubation conditions for testosterone production 
Rat Leydig cell suspensions (0.1 ml), were incubated 
in triplicate in a final volume of 1 ml of Medium 
199 containing 0.1 mM methyl-3-isobutylxanthine. 
1 mg/ml BSA and 20 ng/ml hCG and/or various lipo- 
protein fractions. After incubation, usually for 3 h at 
37°C in an atmosphere of O2 :C02 (95:5”, v/v), the 
reaction was stopped by placing the sample tubes in a 
boiling water bath for 3 min. Water (1 ml) and 
[1,2,6,7-“H(N)]-testosterone (SA 98.8 Ci/mmol, New 
England Nuclear) (10~1, 10,OOOc.p.m. to monitor 
testosterone recovery) were added and the samples 
left in the cold overnight. The next morning the 
samples were extracted with anhydrous diethyl 
ether [26] and assayed for testosterone by radio- 
immunoassay as described by Niswender et al.[27]. 
Binding of [ ‘*‘I]-hCG to testis Leydig cells 
Incubation in a final volume of 1 ml Medium 199 
contained the testis Leydig cells suspension, 
1 mg/ml BSA, [12sI+hCG (200,000c.p.m., 5-10 ng) 
and increasing amounts of unlabeled hCG. After incu- 
bation at 37°C for 2 h in the presence of 02:C02 
(95:5 v/v), 2 ml ice cold medium was added and tubes 
were centrifuged at 100 g for 15 min in the cold. The 
pellets were washed once with 2 ml medium and 
counted for radioactivity in a gamma counter (Searle). 
The specific binding was calculated from the differ- 
ence of total binding to that observed in the presence 
of lOOO-fold excess unlabeled hCG. 
Hormonal treatment of female rats 
Twenty-two to twenty-four day old female Spra- 
gue-Dawley rats (Spartan Research, Inc., Hazlett, MI) 
were used in the present studies. Highly luteinized 
ovaries from these rats were obtained following a 
regimen described by Parlow(28). Rats were injected 
subcutaneously with 5OIU of PMSG and followed 
56 h later with 25 IU of hCG (Sigma). Day 0 was 
taken as the day of hCG injection. 
Preparation of collagenase-dispersed luteal cells 
The collagenase dispersed luteal cells were prepared 
by the procedure described earlier from this labora- 
tory C29.303. 
Incubation conditions for progesterone nwasurement 
Luteal cells (1.5 to 2 x IO”) were incubated in 
0.4 ml of Medium 109 containing 1 mg/ml BSA, and 
where required, 10 ng/ml hCG and/or appropriate 
concentrations of lipoprotein fractions were also 
added. The incubations were performed at 37°C in a 
Dubnoff metabolic shaking water bath gassed with 
02:C02 (95:s v/v). Following incubation. the reac- 
tion was stopped by placing the tubes in a boiling 
water bath for 3 min. Water (0.5 ml) and [1,2-3H(N)]- 
progesterone (SA 55 Ci/mmol) (10 ~1, lO,ooO c.p.m. to 
monitor progesterone recovery) were added and the 
samples left in the cold overnight. The next day 
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Fig. 1. Effect of injection of different doses of 4-APP on body weight, testis weight, plasma cholesterol, 
testosterone and free and esterified cholesterol contents in isolated Leydig cell suspension. Groups of 
four male rats (N-fB-day old) were injected with phosphate buffered saline (PBS pH 4.0) or indicated 
doses of CAPP every day for 3 days. On the fourth day rats were weighed for body weight and then 
killed. The pooled testes from each group were processed for the isolation of Leydig cell suspens%n by 
collagenase treatment as described in *Materials and Methods.” The free cholesterol and cho!isterol 
ester content of Leydig cells were separated by silicic acid/cefite column chromato~aphy, 
samples were extracted with light petroleum ether and 
assayed for progesterone by radioimmunoassay as de- 
scribed previously [31,32]. 
DNA content of the cells was measured by the 
calorimetric procedure of Burton[33]. Total plasma 
or serum cholesterol was determined by the pro- 
cedure of Zak[34]. Cellular free cholesterol and cho- 
lesterol esters were separated according to the pro- 
cedure of Brown et nl.[35]. Cholesterol esters after 
saponification in alcoholic KOH and free cholesterol 
were quantitated by the micromethod of Glick et 
at.[36]. Human plasma LDL (d, 1.019-1.063g/ml) 
and HDL (d, 1.09-1.215 g/ml) were isolated by differ- 
ential ultracentrifugation using KBr for density 
adjustment [37]. Isolated lipoprotein fractions were- 
dialyzed for 36-48 h against three to four changes of 
0.15 M NaCl containing 0.3 mM EDTA. Before use, 
these fractions were dialyzed against 0.15 M NaCl to 
remove EDTA. Purity of lipoprotein fractions was 
checked by agarose gel electrophoresis in 0.05 M bar- 
bital buffer pH 6.8 using precast (Bio-Gram A, 
BioRad) agarose slides. The mass ratio of total choles- 
terol to protein was 1.4: 1 and 1: 3.58 for LDL and 
HDL, respectively. Protein content of lipoproteins 
was determined by a modification of the procedure of 
Lowry et aI.[38] as described by Markwell et al.[39]. 
RESULTS 
Eflect of different doses of 4-APP injection on plasma 
cholesterol, testosterone levels and testicular cell cho- 
Iesterol and sterol ester contents 
As shown in Fig. 1, injection of CAPP at a dose of 
12.5 mg/kg BW or 25mgAcg BW slightly but signifi- 
cantly reduced the body weight. 4-APP treatment, 
however, produced no significant effect on testis 
weight. Injection of different doses of QAPP (3.08, 
6.25, 12.5 and 25 me/kg BW) also reduced the plasma 
cholesterol and testosterone levels in a dose depen- 
dent manner (Fig. 1). In contrast, cholesterol and 
sterol ester contents of interstitial (Leydig) cells were 
not affected by CAPP treatment. 
E$ect o~~~e~j~ doses of4-APP ~jectjon on in vitro 
steroidogenesis in isolated Leydig cell suspension 
Injection of low dose of 4-APP (3.08 mg/kg BW) to 
rats caused a significant inhibition in basal as well as 
hCG, 8 Br-CAMP and cholera toxin stimulated 
steroid production in isolated Leydig cells (Table 1). 
Increasing the 4-APP dose to 6.25 mg/kg BW further 
reduced the steroidogenic capacity of isolated Leydig 
cells both under basal condition and in response to 
various stimulators. Maximum inhibition of basal and 
hormone-stimulated in uitro steroidogenesis was ob- 
served when rats were pretreated with CAPP at a 
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Table 1. Effect of different doses of CAPP injection on hCG, cholera 
toxin and 8 Br-CAMP stimulated steroidogenesis in isolated L.eydig cells 
Testosterone (pg pg DNA-’ + SEM) 
4-APP hCG 8 Br-CAMP Cholera toxin 
(mg/kg BW) Basal (20 ng/ml) (1.5 mM) (1 pg/ml) 
0 181 f 10 1070 f 30 1100 + 31 430 f 38 
3.08 152 + 6 787 + 60 730 f 6 320 * 9 
6.25 108 + 10 584 f 43 710 + 31 340f 15 
12.50 77 f 7 550 f 35 620 f 37 289 f 29 
25 95 + 10 570 f 64 640 f 33 280 f 18 
Groups of four rats were injected with indicated doses of CAPP every 
4 h for 3 days and rats were killed on day 4. The testes were treated with 
collagenase for the isolation of crude Leydig cell suspension. The isolated 
cells were incubated for 3 h with hCG, 8 Br-CAMP or cholera toxin as 
described in “Materials and Methods.” After the incubation, samples 
(medium + cells) were extracted and assayed for testosterone by radio- 
immunoassay. The results are mean of three different experiments. 
dose of 12.5 mg/kg BW. In subsequent experiments 
rats were injected with this dose of CAPP 
(12.5 mg/kg BW) to reduce the circulating levels of 
cholesterol and to monitor the effect on in oirro steroi- 
dogenesis under variable physiological conditions. 
Time dependent qfict of I-APP treatment 
Results presented in Fig. 2 and Table 2 demon- 
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Fig. 2. EtTec’ect of varying 4-APP injection time on plasma 
cholesterol, plasma testosterone, Leydig cell free choles- 
terol and cholesterol ester contents. Groups (6) of 
50-60.day old rats were injected with PBS or CAPP 
(12.5 mg/kg BW) every day for 4 days. After 24 h following 
last injection, the rats were killed and plasma cholesterol 
and testosterone measurements were made using plasma of 
collected blood. Leydig cell isolation and separation of 
cellular cholesterol and cholesterol ester content were car- 
ried out as described in “Materials and Methods:. 
strate time-dependent effect of CAPP (12.5 mg/kg 
BW) injection on plasma cholesterol, testosterone and 
Leydig cell steroidogenesis and sterol contents. Drug 
treatment resulted in a 50% decrease in plasma cho- 
lesterol levels after 1 day of injection and by 2 days 
the cholesterol levels were reduced to 25% of control 
values. Cholesterol was maximally reduced (85%) 
between days 3 and 4. Similarly, CAPP treatment 
deceased serum testosterone levels approximately 40 
and 50% on day 1 and day 2 after the injection. Maxi- 
mum decrease in testosterone levels was observed on 
days 3 and 4. In contrast, cellular cholesterol and 
cholesterol ester contents remained unchanged fol- 
lowing 4-APP injection (Fig. 2). Leydig cell suspen- 
sion prepared from CAPP injected rats exhibited ap 
Table 2. Time-dependent effect of 4-APP injection on in 
rirro steroidogenesis in isolated Leydig celis 
Testosterone (pg’pg DNA-’ f SEM) 
hCG 
Basal (20 &ml) 
Day I 
PBS 175 f 7 831 + 45 
4-APP 192 + 39 784 f 41 
Day 2 
PBS 197 * 11 872 f 53 
CAPP 99_+4 456 + 22 
Day 3 
PBS 204 f 39 1083 f 64 
4-APP 120*25 559 f 13 
Day 4 
PBS 185 f 21 1400& 19 
4-APP 87 f 32 730 f 59 
Groups of rats were injected with saline or 4-APP 
(12.5 mg/kg BW) every 24 h for up 10 4 days. Rats were 
killed on day 1. 2, 3 and 4. The testes were removed, decap- 
sulated., and interstitial (Lcydig ceil) suspensions were pre- 
pared by collagenase digestion. Aliquots of isolated cells 
were incubated with or without hCG (20ng/ml) and in 
vitro testosterone production was followed for 3 h. The 
results are mean of three different experiments 
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Table 3. Timedependent effect of CAPP injection on 
[‘251]-hCG binding to isolated Leydig cell suspension 
4-APP (12.5 mg/kg BW) [‘251]-hCG Binding* 
Treatment (% of control) 
Day 1 73.3 
Day 2 64.9 
Day 3 60.8 
Day 4 53.9 
Experimental details were the same described in “Mater- 
ials and Methods.” 
* Results are mean of three separate experiments. 
proximately 50% inhibition in basal and hCG stimu- 
lated testosterone production compared to cells from 
saline injected rats. The inhibitory effect of 4-APP 
was first observed after two days of drug injection, 
and the effect persisted and remained unchanged after 
3 and 4 days of injection (Table 2). Surprisingly, 
CAPP treatment also produced a significant inhi- 
bition in gonadotropin (12’1-hCG) binding to Leydig 
cells (Table 3). 
Efict of lipoprotein additions on in vitro steroidoge- 
nesis by Leydig and luteal cells obtained from 4-APP 
injected rats 
Results presented in Fig. 3 demonstrate the effect of 
CAPP injection on plasma testosterone and pro- 
gesterone levels in male and pseudopregnant female 
rats. As shown in Fig. 1 and also in Fig. 3, injection of 
CAPP (12.5 mg/kg BW) for 3 days significantly de- 
creased the plasma cholesterol and testosterone levels 
in male rats. Similarly in pseudopregnant female rats, 
CAPP injection drastically reduced the plasma pro- 
gesterone and cholesterol levels. The in oiuo treatment 
of pseudopregnant rats with 4-APP resulted in signifi- 
cant inhibition of basal and hCG stimulated steroido- 
genesis in isolated luteal cells (Fig. 3). Addition of 
h-LDL (75Opg protein/ml) or h-HDL (7OOpg pro- 
tein/ml) to luteal cells isolated from PBS injected rats 
caused about 2-fold increase in basal progesterone 
production and both lipoproteins greatly potentiated 
the gonadotropin-stimulated steroid production. 
Interestingly, addition of h-LDL to luteal cells from 
CAPP injected rats completely reversed the inhibi- 
tory action of the drug on hCG-stimulated progester- 
one accumulation. h-LDL also partially reversed the 
inhibition of basal steroid production Seen in luteal 
cells of CAPP injected rats. h-HDL, although pro- 
ducing identical effects, was slightly less effective 
than h-LDL. In contrast, neither h-LDL nor h-HDL 
was able to overcome the inhibitory effect of CAPP 
seen in Leydig cell steroidogenesis (Fig. 3). Further, 
compared to its lack of effect on Leydig cell choles- 
terol and cholesterol ester contents (Fig. 1 and 2), 
injection of the drug CAPP to pseudopregnant rats 
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Fig. 3. Eliect of CAPP injection to male rats or pseudopregnant rats on steroidogenesis in isolated cells 
in response to gonadotropins and lipoproteins. Pseudopregnancy in 23-day old rats was induced by 
injection of 50 IU PMSG followed 56 h later with a single injection of 25 IU hCG (day 0). On day 3 PBS 
or 4-APP (12.5 mg/kg BW) were injected every day for 3 days. Similarly, male rats were injected with 
PBS or CAPP every day for 3 days. Twenty-four hours after last injection, Leydig cells and luteal cells 
from testes and luteinized ovaries, respectively, were isolated and incubated with lipoproteins and/or 
hCG for steroid production. Testosterone and progesterone on extracted samples were assayed by 
specific radioimmunoassays. A and C refer to males and B and D to females. 
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Fig 4. Effect of CAPP injection to pseudopregnant rats on 
cholesterol and cholesterol ester contents in luteal cells. 
Groups (4) of rats were injected with PBS or CAPP 
(125mg/kgBW) as described in Fig. 3. Cholesterol and 
cholesterol ester from luteal cells were separated by silicic 
acid/celite column chromatography. 
caused a 6%70% decrease in cholesterol ester content 
and a slight but significant reduction in free choles- 
terol levels in luteal cells (Fig. 4). 
Effect of Triton WR-1339 injection 
Further experiments were performed to monitor 
the effect of raising plasma cholesterol levels on Ley- 
dig cell steroidogenesis. This was accomplished by 
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Table 4. Effect of Triton-Wr-1339 injection 
on [‘Z51]-hCG binding to isolated Leydig 
cell suspension 
Days after Triton [‘2JI]-hCG Binding 
Wr-1339 injection (yO of control) 
Day 1 89 
Day 2 72 
Day 3 94 
Groups of four rats were injected with nor- 
mal saline or Triton WR-1339 (1 g/kg BW) 
every 12 h for 1. 2 and 3 days and killed 12 h 
after last injection. [ “‘I]-hCG binding to 
isolated Leydig cell suspension was carried 
out as described in “Materials and 
Methods.” Results are mean of four different 
experiments. 
treating rats with Triton WR-1339, a pharmacological 
agent known to increase circulating cholesterol 
levels [20-223. Results presented in Fig. 5 demon- 
strate that treatment of rats with Triton WR-1339 
caused a 6-fold increase in plasma cholesterol levels 
after one day of detergent injection. The maximum 
increase in plasma cholesterol (lO-11-fold) levels was 
observed after 2 days of treatment and then remained 
elevated up to 3 days. In contrast, Triton WR-1339 
injection caused a maximum reduction in plasma 
DAY DAY 
Fig. 5. Effect of varying Triton WR-1339 injection time on plasma cholesterol and testosterone levels 
and Leydig cell cholesterol and sterol ester contents. Groups of four rats (SO-6Oday old rats) were 
injected wfth normal saline or Triton-Wr-1339 (lgkg BW) every 12 h for 1. 2 or 3 days. After 12 h 
following last injection, plasma cholesterol, testosterone and Leydig cell free cholesterol and sterol esters 
were measured as described in “Materials and Methods.” 
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Table 5. Efiect of Triton WR-1339 injection on in vitro steroidogenesis in isolated Leydig cell 
suspension 
Treatment 
(days) Basal 
Testosterone (pg.pg DNA-’ + SEM) 
h-LDL h-HDL h-LDL 
hCG (750 fig (700 Pg 
(20 @ml) protein/ml) protein/ml) hbG 
h-HDL 
h:G 
Day1 
Saline 
Triton 
172 f 9 1400+84 220 + 23 239 f 16 1310 + 22 1290 + 33 
188 _?I 12 1540 * 160 220 + 17 181 f 16 1270 + 180 1310 + 210 
Day 2 
Saline 
Triton 
176 f 17 1389 + 104 185 f 10 173 f 17 1435 f 65 1175 + 210 
163 f 5 1404 + 170 201 f40 187 + 43 1395 f 33 1371 f 81 
Dav 3 
Saline 
Triton 
176 f 3 1300 f 66 193 f 13 165 + 7 1350 f 49 1480 + 600 
187 + 9 1346 + 220 1737 + 8 205 k 13 1070 f 600 1240 + 87 
Groups of six rats were injected with saline or Triton WR-1339 (1 g/kg BW) every 12 h for 1, 2 
or 3 days. Twenty-four hours after the last injection. the rats were killed and Leydig cells 
suspension were prepared by collagenase treatment as described in the “Materials and Methods”. 
Aliquots of cells were incubated with indicated concentrations of various substnaces. After incu- 
bation for 3 h, samples (Medium + cells) were extracted and assayed for testosterone by radio- 
immunoassay. 
testosterone levels after day 1. Although plasma 
testosterone levels slightly increased on day 2 and day 
3, the drug-mediated inhibition persisted in treated 
groups during the entire period of experiment. Deter- 
gent treatment, however, produced no significant 
effect on Leydig ~11 cholesterol and cholesterol ester 
contents (Fig. 5). 
In vivo treatment of rats with detergent also caused 
a slight decrease in [ ‘2sI]-hCG binding activity to 
isolated Leydig cell suspension (Table 4). Similarly, 
Triton treatment was without any discernable effect 
on steroidogenesis in isolated Leydig cell suspension 
(Table 5). Further addition of h-LDL or h-HDL failed 
to modulate steroidogenesis in Leydig cell suspension 
isolated from testes of rats pretreated with normal 
saline or Triton Wr-1339. 
DISCUSSION 
In the present studies, attempts were made to 
explore the role of circulating plasma cholesterol on 
gonadal steroidogenesis with special emphasis on 
Leydig cell steroidogenesis. The drug QAPP, an ade- 
nine analog, has previously been reported to block 
secretion of all major classes of plasma lipoproteins 
and subsequently lead to a decrease in plasma choles- 
terol levels [6, 18, 19,401. This drug was therefore 
selected to lower circulating plasma cholesterol levels 
and to monitor Leydig cell steroidogenesis in vitro 
and in viuo under identical experimental conditions. 
Subcutaneous administration of CAPP markedly 
reduced the circulating levels of cholesterol in male 
rats in a dose and time-dependent manner. The drug- 
induced decrease in plasma cholesterol was closely 
associated with a parallel decrease in plasma testos- 
terone levels. Further, Leydig cell suspensions isolated 
from testes of CAPP injected rats exhibited a de- 
creased steroidogenic activity both under basal con- 
ditions and also in response to trophic hormone. 
Although maximum testosterone production was con- 
siderably decreased in Leydig cells of 4-APP injected 
rats, these cells still retained the capability to respond 
to gonadotropins. These observations thus support 
the notion that the various enzymes and steps 
involved in testosterone synthesis are probably not 
affected by this treatment. Surprisingly, 4-APP treat- 
ment also slightly decreased the gonadotropin bind- 
ing activity of Leydig cells. However, inhibition of 
gonadotropin-receptor-adenylate cyclase system by 
CAPP cannot be ruled as its sole point of action, 
since Leydig cells also showed decreased steroidoge- 
nesis in response to Bt,cAMP and 8 &-CAMP, agents 
which bypass initial steps of gonadotropin action 
[l-S]. Further, since in Leydig cells only about 10% 
receptors need to be occupied for maximum ex- 
pression of steroidogensis [41], the 60-70x receptor 
concentration retained by cells from CAPP injected 
rats should be sufficient to carry on maximum rate of 
testosterone synthesis. In contrast to the inhibition of 
steroidogenesis seen, CAPP treatment failed to 
modulate the cholesterol esters and free cholesterol 
contents of isolated Leydig cell suspension. These 
results are in agreement with those reported pre- 
viously by Andersen and Dietschy[S] for intact rat 
testis. In addition, our observations that CAPP did 
not affect testes weight, phospholipid, protein syn- 
thesis and energy metabolism of Leydig cells (Azhar 
and Menon, unpublished observation) further rule out 
the possibility that the inhibitory effect of drug on 
steroidogenesis was due to general cytotoxic action. 
Similarly Gerson et a/.[421 found no change in tes- 
titular cholesterol contents following treatment of 
rats with /I-sitosterol although this plant sterol under 
identical experimental conditions produced a signifi- 
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cant drop in plasma cholesterol levels. Further studies 
by Morris and ChaikofF[43], based upon the 
[14C+acetate incorporation into cholesterol con- 
cluded that most of the testicular cholesterol. is syn- 
thesized de novo. Although in the present studies 
4-APP treatment failed to modulate testicular choles- 
terol and sterol ester contents, it drastically reduced 
the steroidogenic capacity of isolated Leydig cells. 
Thus, the present studies as well as in uivo studies 
reported by Andersen and Dietschy[S] support a 
regulatory role of plasma lipoproteins in testicular 
steroidogenesis. 
Further studies were performed to see if the inhibi- 
tory action of CAPP could be reversed by the ad- 
dition of various lipoproteins. The in uivo studies 
reported recently suggest that testes preferentially 
utilize HDL for steroid synthesis [S], while in adre- 
nals cholesterol for steroidogenesis can be obtained 
from HDL [6.8] and/or LDL [lo]. The demon- 
stration of specific receptors for HDL on testicular 
interstitial cell plasma membrane further suggests that 
Leydig ceils are probably equipped with the necessary 
machinery to bind and metabolize the iipopro- 
teinsC44-j. However, all our efforts to reverse the in- 
hibitory action of CAPP by in oitro lipoprotein ad- 
dition were unsuccessful. Further, while CAPP treat- 
ment leads to stimulation of de nova synthesis of cho- 
lesterol in testis [Et], the amount produced probably is 
npt sufficient to support steroidogenesis maximally. 
Contrary to these observations, in luteal cells the in- 
hibitory action of CAPP on steroidogenesis was 
reversed by the addition of LDL or HDL. In ad- 
dition, CAPP treatment drastically reduced the cho- 
lesterol ester content in luteal cells while this treat- 
ment had no effect on Leydig cell cholesterol and 
cholesterol ester content. Thus, results of the present 
study as well as those reported by Schuler et a/.[173 
and Schreiber et a/.[453 for granulosa cells, suggest 
that cells of ovarian origin can effectively utilize LDL 
and/or HDL delivered cholesterol for steroidogenesis, 
whereas in short-term incubated Leydig cells, lipopro- 
teins probably do not support steroidogenesis. How- 
ever, the possibility that during isolation Leydig cells 
lose their cell surface components necessary for lipo- 
protein binding and/or processing cannot be ruled 
out at present. 
Injection of rats with Triton WR-1339 produced 
approximately lo-fold increase in plasma cholesterol, 
an effect observed earlier by Goldfarb[Zl] and Ander- 
son and DietschyC46-J. The detergent mediated in- 
crease in plasma cholesterol levels is due to its ca- 
pacity to block lipid clearance [47-501. Although 
feeding high cholesterol diet could also lead to 
increase in serum cholesterol levels [43,51] it is 
not clear if dietary ingested cholesterol totally gets 
incorporated into lipoproteins. In addition, Triton 
WR-1339 mediated increase in plasma cholesterol 
can be achieved within 2-3 days, compared to 6-12 
days required for diet-induced hypercholesterolemia 
[43,51]. Finally, diet-induced hypercholesterolemia 
may also affect lipoprotein secretion [52]. In contrast. 
to increase in plasma cholesterol levels. detergent 
injection caused a significant inhibition in plasma 
testosterone levels. However. Triton WR-1339 injec- 
tion did not affect the steroidogenic capacity of iso- 
lated Leydig cell suspensions either under basal con- 
ditions or in response to trophic hormone. Since we 
could not detect any change in cholesterol and choles- 
terol ester contents of Leydig cells following Triton 
WR-1339 injection, the inhibition of plasma testos- 
terone could be due to a secondary effect. It is quite 
possible that Triton WR-1339 treatment somehow 
interfered with the release of LH from the pituitary 
and a subsequent inhibition in the in aico testosterone 
production and release into the plasma. 
.In summary, the present studies demonstrate that 
reduction in plasma cholesterol levels by 4-APP treat- 
ment leads to a significant inhibition of in vitro steroi- 
dogenic capacity of gonadal cells. This inhibition of 
steroidogenesis in luteal cells was effectively reversed 
by in vitro addition of LDL or HDL. In contrast, 
coincubation of Leydig cells with LDL or HDL did 
not reverse the inhibitory action of CAPP on testos- 
terone synthesis. It appears, therefore, that Leydig 
and luteal cells probably process and utilize lipopro- 
tein delivered cholesterol for steroidogenesis through 
different mechanisms. 
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